Climb Bio, Inc. (CLYM)
9.14
+0.12
(+1.33%)
USD |
NASDAQ |
Apr 24, 16:00
9.13
-0.01
(-0.11%)
After-Hours: 20:00
Climb Bio Market Cap : 436.60M for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 109.31B |
| Fortress Biotech, Inc. | 75.03M |
| Oramed Pharmaceuticals, Inc. | 155.72M |
| Lyell Immunopharma, Inc. | 331.85M |
| PepGen Inc. | 106.44M |
Market Cap Related Metrics
| Price to Book Value | 2.721 |
| Price | 9.14 |
| Earnings Yield | -9.69% |